ABT congressional trades
Abbott Laboratories (ABT) appears in 48 congressional disclosure rows from 18 members of Congress in 2025–2026 periodic reports: 20 purchases, 27 sales, and 1 exchange, with trade dates from Mar 15, 2023 to Sep 18, 2026. Gilbert Cisneros reported the most, with 6 rows. The median gap between trade date and filing date is 27 days, and 5 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live ABT portfolio or a trading signal.
- 48
- 18
- 20 / 27
- $139K – $910K
- sum of reported ranges
- 2026-09-18
Verified ABT congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 20 purchases, 27 sales, and 1 exchange. Reported owners: Self, Spouse, Joint, Dependent. Transaction dates run from 2023-03-15 to 2026-09-18.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20035622 Filed 2026-10-12 | |
| Rich McCormick | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20035204 Filed 2026-08-14 | |
| Mike Kelly | Abbott Laboratories Common Stock | Sale | Spouse | $1,001 - $15,000 | #20035203 Filed 2026-08-12 | |
| Rick Allen | Abbott Laboratories Common Stock | Sale | Spouse | $15,001 - $50,000 | #20035260 Filed 2026-08-18 | |
| Rick Larsen | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20034977 Filed 2026-07-12 | |
| Gilbert Cisneros | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20034906 Filed 2026-07-02 | |
| Rich McCormick | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20034954 Filed 2026-07-09 | |
| Rich McCormick | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20034954 Filed 2026-07-09 | |
| Josh Gottheimer | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20034693 Filed 2026-06-03 | |
| Gilbert Cisneros | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20034713 Filed 2026-06-08 | |
| Julie Johnson | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20034706 Filed 2026-06-12 | |
| Rick Allen | Abbott Laboratories Common Stock | Sale | Spouse | $15,001 - $50,000 | #20034473 Filed 2026-06-05 | |
| Alan Armstrong | Abbott Laboratories Common Stock | Sale | Self | $15,001 - $50,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Laura Friedman | Abbott Laboratories Common Stock | Exchange | Self | $1,001 - $15,000 | #20034355 Filed 2026-04-17 | |
| Rich McCormick | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20033648 Filed 2026-04-07 | |
| Gilbert Cisneros | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20034144 Filed 2026-03-09 | |
| Thomas Kean | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20034025 Filed 2026-02-19 | |
| Gilbert Cisneros | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20033762 Filed 2026-01-12 | |
| Julie Johnson | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| Julia Letlow | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Byron Donalds | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20033747 Filed 2026-01-07 | |
| Byron Donalds | Abbott Laboratories Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033747 Filed 2026-01-07 | |
| Gilbert Cisneros | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Julie Johnson | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Rich McCormick | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20033610 Filed 2025-12-09 | |
| Rick Larsen | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20032298 Filed 2025-10-16 | |
| Julie Johnson | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| Thomas Kean | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20030946 Filed 2025-08-20 | |
| Josh Gottheimer | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20030848 Filed 2025-08-11 | |
| Lisa McClain | Abbott Laboratories Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Abbott Laboratories Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Jefferson Shreve | Abbott Laboratories Common Stock | Sale | Self | $50,001 - $100,000 | #20030387 Filed 2025-06-22 | |
| Bruce Westerman | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Byron Donalds | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20029092 Filed 2025-04-14 | |
| Byron Donalds | Abbott Laboratories Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20029092 Filed 2025-04-14 | |
| Josh Gottheimer | Abbott Laboratories Common Stock | Sale | Joint | $1,001 - $15,000 | #20029083 Filed 2025-04-10 | |
| Bruce Westerman | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Shelley Capito | Abbott Laboratories | Sale | Spouse | $1,001 - $15,000 | #2f191d07-0340-4367-ba29-a81216bb20e3 Filed 2025-03-06 | |
| Josh Gottheimer | Abbott Laboratories Common Stock | Purchase | Joint | $1,001 - $15,000 | #20027901 Filed 2025-03-06 | |
| Josh Gottheimer | Abbott Laboratories Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026732 Filed 2025-02-10 | |
| Josh Gottheimer | Abbott Laboratories Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026732 Filed 2025-02-10 | |
| Jared Moskowitz | Abbott Laboratories Common Stock | Sale | Self | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Jared Moskowitz | Abbott Laboratories Common Stock | Sale | Dependent | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Jared Moskowitz | Abbott Laboratories Common Stock | Sale | Dependent | $1,001 - $15,000 | #20026731 Filed 2025-02-10 | |
| Emily Randall | Abbott Laboratories Common Stock | Sale | Spouse | $1,001 - $15,000 | #20026756 Filed 2025-02-11 | |
| Thomas Kean | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20026591 Filed 2025-01-22 | |
| Julia Letlow | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Rich McCormick | Abbott Laboratories Common Stock | Purchase | Self | $1,001 - $15,000 | #20030699 Filed 2025-09-17 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
ABT disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Gilbert Cisneros's ABT trades | 6 | 3 | 3 | 2026-09-18 |
| Josh Gottheimer's ABT trades | 6 | 3 | 3 | 2026-05-27 |
| Rich McCormick's ABT trades | 6 | 5 | 1 | 2026-07-30 |
| Byron Donalds's ABT trades | 4 | 2 | 2 | 2025-12-04 |
| Julie Johnson's ABT trades | 4 | 0 | 4 | 2026-05-12 |
| Jared Moskowitz's ABT trades | 3 | 0 | 3 | 2025-01-15 |
| Thomas Kean's ABT trades | 3 | 3 | 0 | 2026-01-29 |
| Bruce Westerman | 2 | 1 | 1 | 2025-04-21 |
| Julia Letlow | 2 | 1 | 1 | 2025-12-08 |
| Lisa McClain | 2 | 1 | 1 | 2025-07-10 |
| Rick Allen | 2 | 0 | 2 | 2026-07-14 |
| Rick Larsen | 2 | 1 | 1 | 2026-07-08 |
| Alan Armstrong | 1 | 0 | 1 | 2026-03-27 |
| Emily Randall | 1 | 0 | 1 | 2025-01-06 |
| Jefferson Shreve | 1 | 0 | 1 | 2025-05-12 |
| Laura Friedman | 1 | 0 | 0 | 2026-03-24 |
| Mike Kelly | 1 | 0 | 1 | 2026-07-17 |
| Shelley Capito | 1 | 0 | 1 | 2025-02-24 |
How long disclosure took
Days from trade date to filing date for 48 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 7
- 16–30 days
- 24
- 31–45 days
- 12
- Over 45 days
- 5
- Median / longest
- 27d / 917d
Source documents
40 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #20035622Filed 2026-10-12 · 1 row
- #20035260Filed 2026-08-18 · 1 row
- #20035204Filed 2026-08-14 · 1 row
- #20035203Filed 2026-08-12 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20034977Filed 2026-07-12 · 1 row
- #20034954Filed 2026-07-09 · 2 rows
- #20034906Filed 2026-07-02 · 1 row
- #20034706Filed 2026-06-12 · 1 row
- #20034713Filed 2026-06-08 · 1 row
- #20034473Filed 2026-06-05 · 1 row
- #20034693Filed 2026-06-03 · 1 row
28 older filings are linked from the transaction table.
What ABT filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Abbott Laboratories financials and filings
Audited SEC figures, what moves ABT, and primary sources.
Compare ABT vs LLY side by side
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
ABT congressional trades: FAQ
Who in Congress traded ABT?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 48 verified ABT rows from 18 members: Alan Armstrong, Bruce Westerman, Byron Donalds, Emily Randall, and 14 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current ABT holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are ABT amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000; $50,001 - $100,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is ABT congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (177 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded ABT.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-10-15. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported ABT and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included